• Michael A Silva, Vijayaragavan Muralidharan, and Darius F Mirza.
• The Liver Unit, University Hospital Birmingham, NHS Trust, Queen Elizabeth Hospital, Edgbadston, Birmingham, UK.
• Semin. Hematol. 2004 Jan 1; 41 (1 Suppl 1): 132-9.

AbstractLiver surgery has long been associated with massive perioperative blood loss and high rates of postsurgery morbidity and mortality. Recent advances in our knowledge of hepatic segmental anatomy have led to the evolution of liver resection, and a growing awareness of the coagulopathy present in cirrhotic patients has produced a greater understanding of the factors influencing surgical hemostasis. This review will examine the risk factors for perioperative hemorrhage in liver disease patients, and will describe current pharmacological, surgical, and radiological methods available for controlling bleeding and achieving effective hemostasis during liver resection and orthotopic liver transplantation (OLT). The potential role of recombinant factor VIIa (rFVIIa) in providing safe hemostasis during such procedures will also be explored. Today, due to careful monitoring and correction of coagulopathy, improved surgical techniques, and judicious patient selection, liver surgery is no longer a high-risk specialty with an unfavorable risk profile, but a safe and widely practiced procedure.

27 keywords...

hide…